The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Lectin-mediated drug targeting: history and applications
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Carbohydrate-Specific Receptors of the Liver
Ashwell, G., & Harford, J. (1982) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.51.070182.002531 · Cited by 1,914
Sharon, N., & Lis, H. (1972) · Science · doi:10.1126/science.177.4053.949 · Cited by 1,706
Receptor-mediated in vitro gene transformation by a soluble DNA carrier system.
Wu, G. Y., & Wu, C. H. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61209-8 · Cited by 855
Drickamer, K., & Taylor, M. E. (1993) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.09.110193.001321 · Cited by 775
Adamson, I. Y. R., & Bowden, D. H. (1974) · PubMed · Cited by 702
The role of selectins in inflammation and disease
Ley, K. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00071-6 · Cited by 682
Transformation of alveolar Type 2 cells to Type 1 cells following exposure to NO2
Evans, M. J., Cabral, L. J., Stephens, R. J., & Freeman, G. (1975) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(75)90059-3 · Cited by 588
Drugs and the Pharmaceutical Sciences
(2010) · Drugs and the pharmaceutical sciences · doi:10.1201/ihcdruphasci · Cited by 586
Animal lectins: a historical introduction and overview
Kilpatrick, D. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00308-2 · Cited by 502
Cited by
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623
Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems
Karimi, M., Ghasemi, A., Sahandi Zangabad, P., Rahighi, R., Moosavi Basri, S. M., Mirshekari, H., Amiri, M., Shafaei Pishabad, Z., Aslani, A., Bozorgomid, M., et al. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00798d · Cited by 1,519
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
Bioavailability of nanoparticles in nutrient and nutraceutical delivery
Acosta, E. (2009) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2008.01.002 · Cited by 874
Protein-based nanocarriers as promising drug and gene delivery systems
Elzoghby, A. O., Samy, W. M., & Elgindy, N. A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.036 · Cited by 852
Basics and Recent Advances in Peptide and Protein Drug Delivery
Bruno, B. J., Miller, G. D., & Lim, C. S. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.104 · Cited by 754
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come
Yingchoncharoen, P., Kalinowski, D. S., & Richardson, D. R. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012070 · Cited by 744
Ricin Poisoning: A Comprehensive Review
Audi, J., Belson, M., Patel, M., Schier, J., & Osterloh, J. (2005) · JAMA · doi:10.1001/jama.294.18.2342 · Cited by 637
Agrawal, M., Saraf, S., Saraf, S., Antimisiaris, S. G., Chougule, M. B., Shoyele, S. A., & Alexander, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.011 · Cited by 630
Self-assembled hyaluronic acid nanoparticles for active tumor targeting
Choi, K. Y., Chung, H., Min, K. H., Yoon, H. Y., Kim, K., Park, J. H., Kwon, I. C., & Jeong, S. Y. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.030 · Cited by 578
Karimi, M., Sahandi Zangabad, P., Ghasemi, A., Amiri, M., Bahrami, M., Malekzad, H., Ghahramanzadeh Asl, H., Mahdieh, Z., Bozorgomid, M., Ghasemi, A., et al. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b00371 · Cited by 500
PEGylation for enhancing nanoparticle diffusion in mucus
Huckaby, J. T., & Lai, S. K. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.08.010 · Cited by 461
Choi, K. Y., Liu, G., Lee, S., & Chen, X. (2012) · Nanoscale · doi:10.1039/c1nr11277e · Cited by 437
A glycobiology review: Carbohydrates, lectins and implications in cancer therapeutics
Ghazarian, H., Idoni, B., & Oppenheimer, S. B. (2011) · Acta Histochemica · doi:10.1016/j.acthis.2010.02.004 · Cited by 433
Polymeric nanoparticles for cancer therapy
Parveen, S., & Sahoo, S. K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860701794353 · Cited by 427
Gastroretentive dosage forms: Overview and special case of Helicobacter pylori
Bardonnet, P. L., Faivre, V., Pugh, W. J., Piffaretti, J. C., & Falson, F. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.10.031 · Cited by 415
The Chemistry and Biological Activities of Peptides from Amphibian Skin Secretions
Xu, X., & Lai, R. (2015) · Chemical Reviews · doi:10.1021/cr4006704 · Cited by 336
PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo
Choi, K. Y., Min, K. H., Yoon, H. Y., Kim, K., Park, J. H., Kwon, I. C., Choi, K., & Jeong, S. Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.010 · Cited by 336
Folate-Mediated Cell Targeting and Cytotoxicity Using Thermoresponsive Microgels
Nayak, S., Lee, H., Chmielewski, J., & Lyon, L. A. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0474143 · Cited by 317
Challenges in design and characterization of ligand-targeted drug delivery systems
Muro, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.052 · Cited by 307
Surface-Modified Nanocarriers for Nose-To-Brain Delivery: From Bioadhesion to Targeting
Sonvico, F., Clementino, A. R., Buttini, F., Colombo, G., Pescina, S., Stanisçuaski Guterres, S., Raffin Pohlmann, A., & Nicoli, S. (2018) · doi:10.20944/preprints201802.0077.v1 · Cited by 306
Carbohydrate recognition by boronolectins, small molecules, and lectins
Jin, S., Cheng, Y., Reid, S., Li, M., & Wang, B. (2010) · Medicinal Research Reviews · doi:10.1002/med.20155 · Cited by 305
Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin
Zhang, N., Ping, Q., Huang, G., Xu, W., Cheng, Y., & Han, X. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.07.026 · Cited by 286
Polymeric nanoparticle drug delivery technologies for oral delivery applications
Pridgen, E. M., Alexis, F., & Farokhzad, O. C. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1018175 · Cited by 269
Choi, K. Y., Saravanakumar, G., Park, J. H., & Park, K. (2012) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.10.029 · Cited by 264
The concanavalin A model of acute hepatitis in mice
Heymann, F., Hamesch, K., Weiskirchen, R., & Tacke, F. (2015) · Laboratory Animals · doi:10.1177/0023677215572841 · Cited by 261
Jeong, S.-H., Jang, J.-H., & Lee, Y.-B. (2023) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00589-5 · Cited by 256
Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery
Vaughan, H. J., Green, J. J., & Tzeng, S. Y. (2020) · Advanced Materials · doi:10.1002/adma.201901081 · Cited by 255
A review of glycosylated carriers for drug delivery
Jain, K., Kesharwani, P., Gupta, U., & Jain, N. K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.033 · Cited by 253
A Historical Review of Brain Drug Delivery
Pardridge, W. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061283 · Cited by 219
Makhlof, A., Fujimoto, S., Tozuka, Y., & Takeuchi, H. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.008 · Cited by 90
Metadata
- Authors
- Bies, C., Lehr, C.-M., & Woodley, J. F.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 56
- Issue
- 4
- Pages
- 425-435
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2023268526
- Cited by
- 414
- References
- 66
- FWCI
- 0.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.